Novo Integrated Sciences Provides Update on Certain Current Events

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) today provides an update with respect to the following previously disclosed pending transactions: (i) the Blacksheep Trust One Billion Dollar Master Collateral Transfer Agreement (the “Collateral Transfer Facility”), (ii) the Letter of Funding Commitment for a direct investment in the Company of $40,000,000 from Sheikh Khaled bin Mohammad bin Fahad Al Thanayan (“Sheikh Khaled”) to develop eldercare facilities in Canada, and (iii) the unsecured 15-year $70,000,000 promissory note with RC Consulting LLC in favor of SCP Tourbillion Monaco for a lump sum debt funding of $57,000,000:

Collateral Transfer Facility. It is important to note that a facility of this nature is not a novelty nor unique to Novo, but rather an effective financing tool in European and Asian marketplaces.

What is the Collateral? The Company’s preliminary due diligence establishing the existence of the collateral in a form and amount sufficient to fulfill the contemplated transfer reflected a GOLD-BACKED GUARANTEE (the “Collateral”).

Validation and Authentication. The pending Collateral validation and authentication will be conducted by an independent PCAOB auditor as the Collateral to be transferred will be reflected on the Company’s balance sheet. Upon verification and authentication of the Collateral, the parties will enter into a Collateral Transfer Agreement and other ancillary agreements related to the book transfer and segregation of collateral.

Monetization. Upon completion of the Collateral transfer, the Company expects to leverage the Collateral in order to obtain a significant line of credit. The line of credit would be secured solely by the Collateral, leaving the balance of the Company’s assets free and clear.

Blacksheep Trust Compensation. Upon successful monetization, the Company will advance the prescribed fee of 15% of the monetization amount to Blacksheep Trust. This is the first time Blacksheep Trust will be entitled to ANY compensation. Upon further draw-down of funds from the Collateral backed line of credit for deal flow, Blacksheep Trust will be entitled to an annual distribution of 10% of net profits as identified by an independent auditor based on the Company’s business activity resulting from the direct investment of any funds derived from monetization.